Unmasking sarcoidosis following SARS-CoV-2 vaccination: A case report.
Fatemeh MohagheghParvaneh HatamiArezoo RefaghatAmir Hassan MatiniZeinab Mohseni AfsharZeinab AryanianPublished in: Clinical case reports (2022)
Sarcoidosis is an inflammatory and granulomatous disorder, developed due to dysregulation between immune response and certain environmental antigens. We hereby report an interesting case of sarcoidosis following COVID-19 vaccination (COVIran Barekat), which presented with inflammation of previous tattoo sites as well as the development of erythema nodosum and systemic lymphadenopathy, suggested a possible link between the COVID vaccination and dysregulation of the inflammatory process and served as a reminder for clinicians to have enough vigilance before proposing a vaccine booster to these patients.
Keyphrases
- sars cov
- coronavirus disease
- oxidative stress
- immune response
- end stage renal disease
- respiratory syndrome coronavirus
- ejection fraction
- newly diagnosed
- chronic kidney disease
- dendritic cells
- peritoneal dialysis
- patient reported outcomes
- interstitial lung disease
- toll like receptor
- rheumatoid arthritis
- risk assessment
- human health
- drug induced
- fine needle aspiration